 Geza Bodor
Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 3 | 2024 | 523 | 1.050 |
Why?
| | Troponin I | 9 | 2017 | 75 | 0.930 |
Why?
| | Anticonvulsants | 1 | 2024 | 209 | 0.750 |
Why?
| | Drug Monitoring | 2 | 2024 | 216 | 0.730 |
Why?
| | Chromatography, Liquid | 2 | 2024 | 424 | 0.700 |
Why?
| | Epilepsy | 1 | 2024 | 322 | 0.650 |
Why?
| | Analgesics, Opioid | 2 | 2018 | 909 | 0.630 |
Why?
| | Substance Abuse Detection | 3 | 2018 | 79 | 0.630 |
Why?
| | Clinical Chemistry Tests | 2 | 2018 | 11 | 0.620 |
Why?
| | Troponin T | 3 | 2017 | 57 | 0.610 |
Why?
| | Troponin | 7 | 1998 | 50 | 0.570 |
Why?
| | Clinical Laboratory Techniques | 1 | 2018 | 94 | 0.560 |
Why?
| | Aviation | 1 | 2016 | 7 | 0.530 |
Why?
| | Chemistry, Clinical | 1 | 2016 | 12 | 0.530 |
Why?
| | Thrombin | 1 | 2017 | 145 | 0.510 |
Why?
| | Myocardial Infarction | 5 | 2017 | 1021 | 0.500 |
Why?
| | Professional Competence | 1 | 2016 | 94 | 0.490 |
Why?
| | Mass Spectrometry | 2 | 2018 | 713 | 0.480 |
Why?
| | Thyrotropin | 1 | 2014 | 109 | 0.450 |
Why?
| | Clinical Decision-Making | 1 | 2016 | 301 | 0.430 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2016 | 580 | 0.420 |
Why?
| | Hyponatremia | 1 | 2013 | 39 | 0.410 |
Why?
| | Carcinoma | 1 | 2014 | 215 | 0.400 |
Why?
| | Myocardium | 8 | 2017 | 978 | 0.370 |
Why?
| | Thyroid Neoplasms | 1 | 2014 | 310 | 0.350 |
Why?
| | Decision Making | 1 | 2016 | 849 | 0.320 |
Why?
| | Schizophrenia | 1 | 2013 | 431 | 0.310 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2014 | 958 | 0.300 |
Why?
| | Immunoassay | 3 | 2018 | 107 | 0.260 |
Why?
| | Pentobarbital | 1 | 2024 | 16 | 0.220 |
Why?
| | Muscular Dystrophies | 2 | 1997 | 35 | 0.170 |
Why?
| | Humans | 20 | 2024 | 129271 | 0.160 |
Why?
| | False Positive Reactions | 3 | 2014 | 114 | 0.140 |
Why?
| | False Negative Reactions | 1 | 2017 | 53 | 0.140 |
Why?
| | Accidents, Aviation | 1 | 2016 | 4 | 0.130 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2016 | 18 | 0.130 |
Why?
| | Muscle, Skeletal | 2 | 1997 | 1613 | 0.130 |
Why?
| | Pain Management | 1 | 2018 | 324 | 0.120 |
Why?
| | Carcinoma, Papillary | 1 | 2014 | 77 | 0.110 |
Why?
| | Iodine Radioisotopes | 1 | 2014 | 143 | 0.110 |
Why?
| | Chromatography, Affinity | 1 | 1992 | 83 | 0.100 |
Why?
| | Radiography | 1 | 2014 | 796 | 0.100 |
Why?
| | Antigens, Tumor-Associated, Carbohydrate | 1 | 1991 | 7 | 0.100 |
Why?
| | Laboratories | 1 | 1992 | 108 | 0.090 |
Why?
| | Fetus | 1 | 1995 | 770 | 0.090 |
Why?
| | Liver Diseases | 1 | 1991 | 290 | 0.080 |
Why?
| | Cocaine | 1 | 1990 | 149 | 0.070 |
Why?
| | Polymyositis | 2 | 1997 | 15 | 0.070 |
Why?
| | Antigens, Neoplasm | 1 | 1989 | 308 | 0.070 |
Why?
| | Middle Aged | 5 | 2017 | 31091 | 0.060 |
Why?
| | Creatine Kinase | 3 | 1995 | 73 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 1991 | 489 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 1992 | 1367 | 0.060 |
Why?
| | Reference Standards | 3 | 2006 | 176 | 0.060 |
Why?
| | Antibody Specificity | 2 | 1997 | 184 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 1997 | 833 | 0.050 |
Why?
| | Quality Control | 2 | 1992 | 163 | 0.050 |
Why?
| | Reference Values | 2 | 1992 | 793 | 0.040 |
Why?
| | Male | 6 | 2014 | 63517 | 0.040 |
Why?
| | Chromatography, Gel | 1 | 1998 | 126 | 0.040 |
Why?
| | Reagent Kits, Diagnostic | 1 | 1998 | 43 | 0.040 |
Why?
| | Biomarkers | 3 | 1998 | 3968 | 0.030 |
Why?
| | Neoplasms | 1 | 1991 | 2449 | 0.030 |
Why?
| | Cross Reactions | 1 | 1997 | 132 | 0.030 |
Why?
| | Immunoenzyme Techniques | 1 | 1997 | 214 | 0.030 |
Why?
| | Female | 6 | 2017 | 68556 | 0.030 |
Why?
| | Phenylisopropyladenosine | 1 | 1995 | 6 | 0.030 |
Why?
| | Purinergic P1 Receptor Agonists | 1 | 1995 | 9 | 0.030 |
Why?
| | Regeneration | 1 | 1997 | 181 | 0.030 |
Why?
| | Isoproterenol | 1 | 1995 | 115 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 1995 | 132 | 0.030 |
Why?
| | Blotting, Western | 1 | 1997 | 1204 | 0.030 |
Why?
| | Adenosine | 1 | 1995 | 227 | 0.030 |
Why?
| | Clinical Enzyme Tests | 1 | 1993 | 10 | 0.030 |
Why?
| | Phosphoproteins | 1 | 1995 | 332 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1992 | 109 | 0.030 |
Why?
| | Muscular Diseases | 1 | 1993 | 107 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1992 | 206 | 0.020 |
Why?
| | Hybridomas | 1 | 1992 | 235 | 0.020 |
Why?
| | Immunoblotting | 1 | 1992 | 305 | 0.020 |
Why?
| | Dogs | 1 | 1992 | 382 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 1995 | 1691 | 0.020 |
Why?
| | Rabbits | 1 | 1992 | 777 | 0.020 |
Why?
| | Diagnosis, Differential | 2 | 1993 | 1432 | 0.020 |
Why?
| | Cattle | 1 | 1992 | 977 | 0.020 |
Why?
| | Immunologic Techniques | 1 | 1989 | 39 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2056 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 1989 | 162 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 1992 | 848 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1992 | 2835 | 0.020 |
Why?
| | Kidney Failure, Chronic | 1 | 1993 | 546 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1990 | 1288 | 0.020 |
Why?
| | Troponin C | 1 | 2006 | 5 | 0.020 |
Why?
| | Calibration | 1 | 2006 | 140 | 0.020 |
Why?
| | Pregnancy | 1 | 1995 | 6391 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2006 | 1304 | 0.010 |
Why?
| | Adult | 3 | 1995 | 35497 | 0.010 |
Why?
| | Postoperative Complications | 1 | 1994 | 2473 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 1989 | 1173 | 0.010 |
Why?
| | Adenocarcinoma | 1 | 1989 | 898 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 1989 | 1016 | 0.010 |
Why?
| | Sensitivity and Specificity | 2 | 1994 | 1839 | 0.010 |
Why?
| | Regression Analysis | 1 | 2001 | 991 | 0.010 |
Why?
| | Adenosine-5'-(N-ethylcarboxamide) | 1 | 1995 | 11 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 1995 | 29 | 0.010 |
Why?
| | Sarcoplasmic Reticulum | 1 | 1995 | 45 | 0.010 |
Why?
| | Mice | 1 | 1992 | 16915 | 0.010 |
Why?
| | Sarcolemma | 1 | 1995 | 40 | 0.010 |
Why?
| | Guinea Pigs | 1 | 1995 | 157 | 0.010 |
Why?
| | Retrospective Studies | 1 | 1992 | 14461 | 0.010 |
Why?
| | Animals | 2 | 1995 | 35309 | 0.010 |
Why?
| | Calcium-Binding Proteins | 1 | 1995 | 211 | 0.010 |
Why?
| | Myocardial Contraction | 1 | 1995 | 335 | 0.010 |
Why?
| | Algorithms | 1 | 2001 | 1613 | 0.010 |
Why?
| | Isoenzymes | 1 | 1993 | 302 | 0.010 |
Why?
| | Muscles | 1 | 1993 | 321 | 0.010 |
Why?
| | Carrier Proteins | 1 | 1995 | 742 | 0.010 |
Why?
| | Vascular Surgical Procedures | 1 | 1994 | 294 | 0.010 |
Why?
| | Phosphorylation | 1 | 1995 | 1710 | 0.010 |
Why?
| | Running | 1 | 1993 | 223 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1995 | 781 | 0.010 |
Why?
| | Incidence | 1 | 1994 | 2636 | 0.000 |
Why?
| | Risk Factors | 1 | 1994 | 9746 | 0.000 |
Why?
|
|
Bodor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|